APA

Carles J., Domenech M., Gelabert-Mas A., Nogue M., Tabernero J. M., Arcusa A., Guasch I., Miguel A., Ballesteros J. J. & Fabregat X. (19980702). Phase II study of estramustine and vinorelbine in hormone-refractory prostate carcinoma patients. : Acta oncologica (Stockholm, Sweden).

Chicago

Carles J, Domenech M, Gelabert-Mas A, Nogue M, Tabernero J M, Arcusa A, Guasch I, Miguel A, Ballesteros J J and Fabregat X. 19980702. Phase II study of estramustine and vinorelbine in hormone-refractory prostate carcinoma patients. : Acta oncologica (Stockholm, Sweden).

Harvard

Carles J., Domenech M., Gelabert-Mas A., Nogue M., Tabernero J. M., Arcusa A., Guasch I., Miguel A., Ballesteros J. J. and Fabregat X. (19980702). Phase II study of estramustine and vinorelbine in hormone-refractory prostate carcinoma patients. : Acta oncologica (Stockholm, Sweden).

MLA

Carles J, Domenech M, Gelabert-Mas A, Nogue M, Tabernero J M, Arcusa A, Guasch I, Miguel A, Ballesteros J J and Fabregat X. Phase II study of estramustine and vinorelbine in hormone-refractory prostate carcinoma patients. : Acta oncologica (Stockholm, Sweden). 19980702.